Publications by authors named "David Tupper"

Claim this Profile
K
Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study.
Anne M Murray, Yelena Slinin, David E Tupper, Sarah L Pederson, Cynthia Davey

Am J Nephrol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral blood flow characteristics following hemodialysis initiation in older adults: A prospective longitudinal pilot study using arterial spin labeling imaging.
Xiufeng Li, Yelena X Slinin, Lin Zhang, Donald R Dengel, David Tupper

Neuroimage Clin· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1,3)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor.
Junliang Hao, James P Beck, John M Schaus, Joseph H Krushinski, Qi Chen, David Tupper

J Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of acute head injury in an emergency department population using sport concussion assessment tool - 3rd edition.
Abdullah Bin Zahid, Molly E Hubbard, Vikalpa M Dammavalam, David Y Balser, Gritz Pierre, David E Tupper

Appl Neuropsychol Adult· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of prior contact sports play and concussion among orthopedic and neurosurgical department chairs.
Je Yeong Sone, S Courtney-Kay Lamb, Kristina Techar, Vikalpa Dammavalam, Mohit Uppal, David Tupper

J Neurosurg Pediatr· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Risk of Severe Cognitive Impairment in Advanced Chronic Kidney Disease.
Christine M Burns, David S Knopman, David E Tupper, Cynthia S Davey, Yelena M Slinin

J Gerontol A Biol Sci Med Sci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.
Anne M Murray, Elizabeth J Bell, David E Tupper, Cynthia S Davey, Sarah L Pederson

Am J Kidney Dis· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu2 Receptor Agonist.
James A Monn, Lourdes Prieto, Lorena Taboada, Junliang Hao, Matthew R Reinhard, David Tupper

J Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological characterization of C4-disubstituted analogs of 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate: identification of a potent, selective metabotropic glutamate receptor agonist and determination of agonist-bound human mGlu2 and mGlu3 amino terminal domain structures.
James A Monn, Lourdes Prieto, Lorena Taboada, Concepcion Pedregal, Junliang Hao, David Tupper

J Med Chem· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of non-traumatic out-of-hospital cardiac arrest with active compression decompression cardiopulmonary resuscitation plus an impedance threshold device.
Ralph J Frascone, Marvin A Wayne, Robert A Swor, Brian D Mahoney, Robert M Domeier, David E Tupper

Resuscitation· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropsychological assessment: a valuable tool in the diagnosis and management of neurological, neurodevelopmental, medical, and psychiatric disorders.
Michelle Braun, David Tupper, Paul Kaufmann, Michael McCrea, Karen Postal

Cogn Behav Neurol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milestones in treatment: the tipping point and the ResQ Trial.
Demetris Yannopoulos, Tom P Aufderheide, Ralph J Frascone, Marvin A Wayne, Brian D Mahoney, David E Tupper

Lancet· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive impairment in peritoneal dialysis patients.
Paramjit Kalirao, Sarah Pederson, Robert N Foley, Ali Kolste, David Tupper

Am J Kidney Dis· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial.
Tom P Aufderheide, Ralph J Frascone, Marvin A Wayne, Brian D Mahoney, Robert A Swor, David E Tupper

Lancet· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chapter 53: rehabilitation therapies.
David E Tupper

Handb Clin Neurol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures.
Anne M Murray, Sarah L Pederson, David E Tupper, Angela K Hochhalter, Wendy A Miller

Am J Kidney Dis· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obituary--Evgenia Davydovna Homskaya.
Janna M Glozman, David E Tupper

Neuropsychol Rev· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Kurt Rasmussen, Mark J Benvenga, Frank P Bymaster, David O Calligaro, Ilene R Cohen, David E Tupper

J Pharmacol Exp Ther· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.
Lorraine Axford, John R Boot, Terrence M Hotten, Martine Keenan, Fionna M Martin, David E Tupper

Bioorg Med Chem Lett· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis